Serpil Erciş
Impact in
- Periodontics top 5%
- Oral microbiology and periodontitis research
- Pharmaceutical Science top 5%
- Advanced Drug Delivery Systems
Papers in
-
- Antimicrobial Resistance in Staphylococcus 7
-
- Pneumonia and Respiratory Infections 4
- Co-authors
- Gülşen Hasçelik (18 shared papers)Hakan Akıncıbay (1 shared paper)Clive Wilson (1 shared paper)G İkinci (1 shared paper)Sevda Şenel (1 shared paper)A. Atilla Hıncal (1 shared paper)Banu Sancak (5 shared papers)Şule Çolakoğlu (1 shared paper)
- Journals
- Journal of Antimicrobial Chemotherapy (2 papers)Annals of Oncology (1 paper)International Journal of Pharmaceutics (1 paper)International Journal of Antimicrobial Agents (1 paper)European Journal of Clinical Microbiology & Infectious Diseases (1 paper)
- Partner nations
- TürkiyeIranUnited States
In The Last Decade
Serpil Erciş
28 papers receiving 457 citations
Peers
Comparison fields: 5 of 78
- Periodontics 67
- Pharmaceutical Science 81
- Molecular Medicine 56
- Clinical Biochemistry 69
- Infectious Diseases 128
Countries citing papers authored by Serpil Erciş
This map shows the geographic impact of Serpil Erciş's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Serpil Erciş with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Serpil Erciş more than expected).
Fields of papers citing papers by Serpil Erciş
This network shows the impact of papers produced by Serpil Erciş. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Serpil Erciş. The network helps show where Serpil Erciş may publish in the future.
Co-authors
The 25 scholars most cited alongside Serpil Erciş, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 185 | |
| 2 | 2005 | 67 | |
| 3 | 2006 | 59 | |
| 4 | 2005 | 27 | |
| 5 | 2005 | 25 | |
| 6 | 2005 | 17 | |
| 7 | 2008 | 17 | |
| 8 | Nalidixic acid resistance in Salmonella strains with decreased susceptibility to ciprofloxacin isolated from humans in Turkey. | 2006 | 12 |
| 9 | Validation of urinary antigen test for Streptococcus pneumoniae in patients with pneumococcal pneumonia. | 2006 | 11 |
| 10 | 2006 | 10 | |
| 11 | 2007 | 10 | |
| 12 | [Salmonella enterica serotypes and Salmonella infections: a multicenter study covering ten provinces in Turkey]. | 2004 | 10 |
| 13 | Evaluation of the Helicobacter pylori stool antigen test (HpSA) for the detection of Helicobacter pylori infection and comparison with other methods. | 2003 | 9 |
| 14 | 2007 | 8 | |
| 15 | [The prevalence of nasopharyngeal Neisseria meningitidis carriage, serogroup distribution, and antibiotic resistance among healthy children in Cankaya municipality schools of Ankara province]. | 2005 | 7 |
| 16 | [Investigation of SCCmec types and Panton-Valentine leukocidin in community-acquired and nosocomial Staphylococcus aureus strains: comparing skin and soft tissue infections to the other infections]. | 2012 | 6 |
| 17 | 2006 | 5 | |
| 18 | 2008 | 5 | |
| 19 | [Investigation of macrolide-lincosamide-streptogramin B (MLS(B)) and telithromycin resistance in clinical strains of staphylococci]. | 2010 | 4 |
| 20 | Does granulocyte-macrophage colony-stimulating factor prevent bacterial translocation in rats with surgical trauma and obstructive jaundice? | 2009 | 2 |
About Serpil Erciş
Serpil Erciş is a scholar working on Infectious Diseases, Epidemiology, Food Science, Public Health, Environmental and Occupational Health and Molecular Medicine, having authored 28 papers that have together received 505 indexed citations. Recurring topics across this work include Antimicrobial Resistance in Staphylococcus (7 papers), Salmonella and Campylobacter epidemiology (6 papers), Antibiotic Resistance in Bacteria (5 papers), Streptococcal Infections and Treatments (4 papers), Pneumonia and Respiratory Infections (4 papers), Antibiotic Use and Resistance (3 papers), Bacterial Identification and Susceptibility Testing (3 papers) and Bacterial Infections and Vaccines (2 papers). The work is most often cited by research in Periodontics (67 citations), Pharmaceutical Science (81 citations), Molecular Medicine (56 citations), Clinical Biochemistry (69 citations) and Infectious Diseases (128 citations). Serpil Erciş has collaborated with scholars based in Türkiye, Iran and United States. Frequent co-authors include Gülşen Hasçelik, Hakan Akıncıbay, Clive Wilson, G İkinci, Sevda Şenel, A. Atilla Hıncal, Banu Sancak, Şule Çolakoğlu, Deniz Gür and Ömrüm Uzun. Their work appears in journals such as Journal of Antimicrobial Chemotherapy, Annals of Oncology, International Journal of Pharmaceutics, International Journal of Antimicrobial Agents and European Journal of Clinical Microbiology & Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.